Asymptomatic Middle East Respiratory Syndrome coronavirus infection using a serologic survey in Korea
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
OBJECTIVES: The rates of asymptomatic infection with Middle East Respiratory Syndrome (MERS) coronavirus vary. A serologic study was conducted to determine the asymptomatic MERS infection rate in healthcare workers and non-healthcare workers by exposure status. METHODS: Study participants were selected from contacts of MERS patients based on a priority system in 4 regions strongly affected by the 2015 MERS outbreak. A sero-epidemiological survey was performed in 1,610 contacts (average duration from exposure to test, 4.8 months), and the collected sera were tested using an enzyme-linked immunespecific assay (ELISA), immunofluorescence assay (IFA), and plaque reduction neutralization antibody test (PRNT). Among the 1,610 contacts, there were 7 ELISA-positive cases, of which 1 exhibited positive IFA and PRNT results. RESULTS: The asymptomatic infection rate was 0.060% (95% confidence interval, 0.002 to 0.346). The asymptomatic MERS case was a patient who had been hospitalized with patient zero on the same floor of the hospital at the same time. The case was quarantined at home for 2 weeks after discharge, and had underlying diseases, including hypertension, angina, and degenerative arthritis. CONCLUSIONS: The asymptomatic infection was acquired via healthcare-associated transmission. Thus, it is necessary to extend serologic studies to include inpatient contacts who have no symptoms.
Abstract
OBJECTIVES: The rates of asymptomatic infection with Middle East Respiratory Syndrome (MERS) coronavirus vary. A serologic study was conducted to determine the asymptomatic MERS infection rate in healthcare workers and non-healthcare workers by exposure status. METHODS: Study participants were selected from contacts of MERS patients based on a priority system in 4 regions strongly affected by the 2015 MERS outbreak. A sero-epidemiological survey was performed in 1,610 contacts (average duration from exposure to test, 4.8 months), and the collected sera were tested using an enzyme-linked immunespecific assay (ELISA), immunofluorescence assay (IFA), and plaque reduction neutralization antibody test (PRNT). Among the 1,610 contacts, there were 7 ELISA-positive cases, of which 1 exhibited positive IFA and PRNT results. RESULTS: The asymptomatic infection rate was 0.060% (95% confidence interval, 0.002 to 0.346). The asymptomatic MERS case was a patient who had been hospitalized with patient zero on the same floor of the hospital at the same time. The case was quarantined at home for 2 weeks after discharge, and had underlying diseases, including hypertension, angina, and degenerative arthritis. CONCLUSIONS: The asymptomatic infection was acquired via healthcare-associated transmission. Thus, it is necessary to extend serologic studies to include inpatient contacts who have no symptoms.
참고문헌 (35)
- de Groot RJ, "Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group", J Virol, 87, pp.7790~7792 (2013)[DOI]
- van Boheemen S, "Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans", MBio, 3, pp.e00473~12 (2012)
- Zaki AM, "Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia", N Engl J Med, 367, pp.1814~1820 (2012)[DOI]
- Assiri A, "Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study", Lancet Infect Dis, 13, pp.752~761 (2013)[DOI]
- Al-Tawfiq JA, "Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients", Clin Infect Dis, 59, pp.160~165 (2014)[DOI]
- Assiri A, "Hospital outbreak of Middle East respiratory syndrome coronavirus", N Engl J Med, 369, pp.407~416 (2013)[DOI]
- Al-Tawfiq JA, "Middle East respiratory syndrome coronavirus: epidemiology and disease control measures", Infect Drug Resist, 7, pp.281~287 (2014)
- Al-Abdallat MM, "Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description", Clin Infect Dis, 59, pp.1225~1233 (2014)[DOI]
- 최재욱, "한국 메르스 감염의 역학현황과 공중보건학적 대응조치 방향", 대한의사협회지, 58(6), pp.487~497 (2015), 대한의사협회[DOI]
- Memish ZA, "Middle East respiratory syndrome coronavirus infection control: the missing piece?", Am J Infect Control, 42, pp.1258~1260 (2014)[DOI]
- Ki M, "2015 MERS outbreak in Korea: hospital-to-hospital transmission", Epidemiol Health, 37, pp.e2015033~ (2015)[DOI]
- "Middle East respiratory syndrome coronavirus (MERS-CoV) - update"[URL]
- "Middle East respiratory syndrome coronavirus (MERS-CoV) - update"[URL]
- Oboho IK, "2014 MERS-CoV outbreak in Jeddah--a link to health care facilities", N Engl J Med, 372, pp.846~854 (2015)[DOI]
- Park GE, "Control of an outbreak of Middle East respiratory syndrome in a tertiary hospital in Korea", Ann Intern Med, 165, pp.87~93 (2016)[DOI]
- Kim CJ, "Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity", Clin Microbiol Infect, 22, pp.880~886 (2016)[DOI]
- Gossner C, "Human-dromedary camel interactions and the risk of acquiring zoonotic Middle East respiratory syndrome coronavirus infection", Zoonoses Public Health, 63, pp.1~9 (2016)[DOI]
- Al Hammadi ZM, "Asymptomatic MERS-CoV infection in humans possibly linked to infected camels imported from Oman to United Arab Emirates, May 2015", Emerg Infect Dis, 21, pp.2197~2200 (2015)[DOI]
- Hemida MG, "Lack of Middle East respiratory syndrome coronavirus transmission from infected camels", Emerg Infect Dis, 21, pp.699~701 (2015)[DOI]
- 정현석, "Mental health status of people isolated due to Middle East Respiratory Syndrome", Epidemiology and Health, 38, pp.1~7 (2016), 한국역학회[DOI]
- Kim SW, "Risk factors for transmission of Middle East respiratory syndrome coronavirus infection during the 2015 outbreak in South Korea", Clin Infect Dis, 64, pp.551~557 (2017)
- Cohen BJ, "Plaque reduction neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination", Vaccine, 26, pp.59~66 (2007)[DOI]
- Park YS, "The first case of the 2015 Korean Middle East Respiratory Syndrome outbreak", Epidemiol Health, 37, pp.e2015049~ (2015)[DOI]
- Kim KM, "Epidemiologic features of the first MERS outbreak in Korea: focus on Pyeongtaek St. Mary's Hospital", Epidemiol Health, 37, pp.e2015041~ (2015)[DOI]
- Muller MA, "Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study", Lancet Infect Dis, 15, pp.629~ (2015)[DOI]
- Memish ZA, "Family cluster of Middle East respiratory syndrome coronavirus infections", N Engl J Med, 368, pp.2487~2494 (2013)[DOI]
- Memish ZA, "Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study", Clin Microbiol Infect, 20, pp.469~474 (2014)[DOI]
- Yoo W, "The effects of SNS communication: how expressing and receiving information predict MERS-preventive behavioral intentions in South Korea", Comput Human Behav, 62, pp.34~43 (2016)[DOI]
- McNab C, "What social media offers to health professionals and citizens", Bull World Health Organ, 87, pp.566~ (2009)[DOI]
- Bauch CT, "Assessing the pandemic potential of MERS-CoV", Lancet, 382, pp.662~664 (2013)[DOI]
- Breban R, "Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk", Lancet, 382, pp.694~699 (2013)[DOI]
- Lee C, "Strengthening epidemiologic investigation of infectious diseases in Korea: lessons from the Middle East Respiratory Syndrome outbreak", Epidemiol Health, 37, pp.e2015040~ (2015)[DOI]
- Park WB, "Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea", Emerg Infect Dis, 21, pp.2186~2189 (2015)[DOI]
- Payne DC, "Persistence of antibodies against Middle East respiratory syndrome coronavirus", Emerg Infect Dis, 22, pp.1824~1826 (2016)[DOI]
- Cao WC, "Disappearance of antibodies to SARS-associated coronavirus after recovery", N Engl J Med, 357, pp.1162~1163 (2007)[DOI]
